Cited by

• Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase.

  Kim HB, Bacik JP, Wu R, Jha RK, Hebron M, Triandafillou C, McCown JE, Baek NI, Kim JH, Kim YJ, Goulding CW, Strauss CEM, Schmidt JG, Shetye GS, Ryoo S, Jo EK, Jeon YH, Hung LW, Terwilliger TC, Kim CY. Kim HB, et al. PLoS One. 2022 Nov 17;17(11):e0277670. doi: 10.1371/journal.pone.0277670. eCollection 2022. PLoS One. 2022. PMID: 36395154 Free PMC article.
• Digital Image Analysis of Heterogeneous Tuberculosis Pulmonary Pathology in Non-Clinical Animal Models using Deep Convolutional Neural Networks.

  Asay BC, Edwards BB, Andrews J, Ramey ME, Richard JD, Podell BK, Gutiérrez JFM, Frank CB, Magunda F, Robertson GT, Lyons M, Ben-Hur A, Lenaerts AJ. Asay BC, et al. Sci Rep. 2020 Apr 8;10(1):6047. doi: 10.1038/s41598-020-62960-6. Sci Rep. 2020. PMID: 32269234 Free PMC article.
• The DosR regulon of M. tuberculosis and antibacterial tolerance.

  Bartek IL, Rutherford R, Gruppo V, Morton RA, Morris RP, Klein MR, Visconti KC, Ryan GJ, Schoolnik GK, Lenaerts A, Voskuil MI. Bartek IL, et al. Tuberculosis (Edinb). 2009 Jul;89(4):310-6. doi: 10.1016/j.tube.2009.06.001. Epub 2009 Jul 3. Tuberculosis (Edinb). 2009. PMID: 19577518 Free PMC article.
• Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.

  Wolff KA, Nguyen HT, Cartabuke RH, Singh A, Ogwang S, Nguyen L. Wolff KA, et al. Antimicrob Agents Chemother. 2009 Aug;53(8):3515-9. doi: 10.1128/AAC.00012-09. Epub 2009 Jun 15. Antimicrob Agents Chemother. 2009. PMID: 19528288 Free PMC article.
• A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.

  Clewe O, Wicha SG, de Vogel CP, de Steenwinkel JEM, Simonsson USH. Clewe O, et al. J Antimicrob Chemother. 2018 Feb 1;73(2):437-447. doi: 10.1093/jac/dkx380. J Antimicrob Chemother. 2018. PMID: 29136155 Free PMC article.